{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:07:46Z","timestamp":1773079666079,"version":"3.50.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134287","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T18:07:12Z","timestamp":1438970832000},"page":"e0134287","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01496989","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Juliet","family":"Mpendo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaudensia","family":"Mutua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Nyombayire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosine","family":"Ingabire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Nanvubya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omu","family":"Anzala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Karita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Kopycinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Len","family":"Dally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Syvertsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Lehrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine H.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E.","family":"Fast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical Applications of DNA Vaccines: Current Progress","volume":"53","author":"B Ferraro","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4161\/hv.22062","article-title":"What you always needed to know about electroporation based DNA vaccines","volume":"8","author":"A Gothelf","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"2\u20133","key":"ref3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"L Li","year":"2012","journal-title":"J Biotechnol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"NY Sardesai","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"5491","key":"ref5","doi-asserted-by":"crossref","first-page":"p486","DOI":"10.1126\/science.290.5491.486","article-title":"Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination","volume":"290","author":"D Barouch","year":"2000","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"S Flingai","year":"2013","journal-title":"Front Immunol"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"M Del Vecchio","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"L Lyakh","year":"2008","journal-title":"Immunological reviews"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"G Trinchieri","year":"2003","journal-title":"Nature reviews Immunology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.gt.3300847","article-title":"Electropermeabilization of skeletal muscle enhances gene transfer in vivo","volume":"6","author":"I Mathiesen","year":"1999","journal-title":"Gene Ther"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1586\/erv.10.42","article-title":"Electroporation for DNA immunization: clinical application","volume":"9","author":"S van Drunen Littel-van den Hurk","year":"2010","journal-title":"Expert review of vaccines"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"G Widera","year":"2000","journal-title":"J Immunol"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/mt.2010.112","article-title":"Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques","volume":"18","author":"LA Hirao","year":"2010","journal-title":"Mol Ther"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/JVI.00055-07","article-title":"Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques","volume":"81","author":"A Luckay","year":"2007","journal-title":"J Virol"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/hum.2009.067","article-title":"DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer","volume":"20","author":"L Low","year":"2009","journal-title":"Hum Gene Ther"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","article-title":"Electrochemotherapy in treatment of tumours","volume":"34","author":"G Sersa","year":"2008","journal-title":"European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"e19252","DOI":"10.1371\/journal.pone.0019252","article-title":"Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers","volume":"6","author":"S Vasan","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"e29231","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"SA Kalams","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"SA Kalams","year":"2013","journal-title":"J Infect Dis"},{"issue":"S1","key":"ref20","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1089\/aid.2014.5019.abstract","article-title":"An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults","volume":"30","author":"CM Hay","year":"2014","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"e41936","DOI":"10.1371\/journal.pone.0041936","article-title":"A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults","volume":"7","author":"MC Keefer","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"e90378","DOI":"10.1371\/journal.pone.0090378","article-title":"Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults","volume":"9","author":"J Kopycinski","year":"2014","journal-title":"PLoS One"},{"key":"ref23","article-title":"Enhanced control of pathogenic SIVmac239 replication in macaques immunized with a plasmid IL12 and a DNA prime, viral vector boost vaccine regimen","author":"N Winstone","year":"2011","journal-title":"J Virol"},{"issue":"21","key":"ref24","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1016\/j.vaccine.2005.08.024","article-title":"Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice","volume":"24","author":"MA Egan","year":"2006","journal-title":"Vaccine"},{"issue":"21","key":"ref25","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1016\/j.vaccine.2005.10.035","article-title":"A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques","volume":"24","author":"EB Schadeck","year":"2006","journal-title":"Vaccine"},{"issue":"1\u20132","key":"ref26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0005-2736(00)00242-X","article-title":"Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine","volume":"1468","author":"CJ Pachuk","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CVI.00326-08","article-title":"Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents","volume":"16","author":"MJ Boaz","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/650492","article-title":"Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV-1 Vaccine Candidates","volume":"201","author":"A Spentzou","year":"2010","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"ref29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-1759(02)00510-0","article-title":"Evaluation of antigen-specific responses using in vitro enriched T cells","volume":"274","author":"N Jones","year":"2003","journal-title":"J Immunol Methods"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0090-1229(91)90139-2","article-title":"Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: evidence for inter-T cell-mediated cytolysis","volume":"58","author":"JT Wong","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1371\/journal.pone.0012873","article-title":"Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa","volume":"5","author":"W Jaoko","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/650299","article-title":"A Phase I\/II Study of a Multiclade HIV-1 DNA Plasmid Prime and Recombinant Adenovirus-type 5 Boost Vaccine in HIV Uninfected East Africans (RV 172)","volume":"201","author":"H Kibuuka","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"e9015","DOI":"10.1371\/journal.pone.0009015","article-title":"Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses","volume":"5","author":"RA Koup","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1128\/JVI.00138-10","article-title":"Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime\/Boost Vaccination","volume":"84","author":"SA Freel","year":"2010","journal-title":"J Virol"},{"key":"ref35","article-title":"Initial HIV- 1 Antigen-specific CD8+ T cells In Acute HIV-1 Inhibit Transmitted Founder Virus Replication","author":"SA Freel","year":"2012","journal-title":"J Virol"},{"issue":"16","key":"ref36","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"A Saez-Cirion","year":"2007","journal-title":"PNAS"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.4049\/jimmunol.0803928","article-title":"Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses","volume":"182","author":"A Saez-Cirion","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/infdis\/jis379","article-title":"Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection","volume":"206","author":"H Yang","year":"2012","journal-title":"J Infect Dis"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/156652310791823425","article-title":"Cancer electrogene therapy with interleukin-12","volume":"10","author":"M Cemazar","year":"2010","journal-title":"Current gene therapy"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00262-014-1523-1","article-title":"Interleukin 12: still a promising candidate for tumor immunotherapy?","volume":"63","author":"W Lasek","year":"2014","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"26","key":"ref41","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1016\/j.vaccine.2006.11.070","article-title":"Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques","volume":"25","author":"SY Chong","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4161\/hv.21407","article-title":"IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques","volume":"8","author":"R Jalah","year":"2012","journal-title":"Hum Vaccin Immunother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:26:50Z","timestamp":1589020010000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134287"}},"subtitle":[],"editor":[{"given":"Thomas L","family":"Richie","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134287","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]}}}